Avoiding a PR Nightmare: How Spark Therapeutics Overcame a Potential Crisis in the Launch of Their First Gene Therapy
On December 19, 2017, the FDA approved a novel gene therapy that treats diseases that affect vision. Luxturna™, from Spark Therapeutics, treats a number of retinal diseases cause
Great Minds Think Similarly: The Pros and Cons of Biosimilars
Ever wish you could replicate the taste of that $200 bottle of wine that has been aged to perfection over the past four decades? This task is a near impossibility, as it requires y
Improvised Marketing
Chicago is home to many iconic offerings – deep dish, the Cubs (or the White Sox, whatever floats your boat), and of course, CG Life! Another hometown legendary offering is the a